Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceHeart & metabolic

Vitamin D3 + K2 Combo

The story that K2 routes calcium into bone and away from arteries is a mechanistic hypothesis that has now been properly tested — and the two best randomised trials of vitamin D plus K2 found no slowing of arterial or valve calcification. The combo is cheap and safe; it just does not do the job it is sold for.

What the science says

  • Slows arterial and valve calcification Limited evidence

    The AVADEC trial randomised 365 men with aortic valve calcification to 720 µg/day MK-7 plus 25 µg vitamin D or placebo for 24 months: there was no significant difference in progression of the aortic valve calcium score. A companion analysis in men with coronary artery disease found no reduction in coronary calcification progression either. These are the largest, longest and best-designed tests of the central marketing claim, and both were negative on their primary endpoint.

  • K2 makes high-dose vitamin D safe by preventing hypercalcaemia Limited evidence

    There is no controlled evidence for this. Vitamin D toxicity is a dose-and-duration problem, and it presents as hypercalcaemia and hypercalciuria regardless of vitamin K status. Adding K2 does not license taking 10,000 IU of D3, and treating it as a safety net is the most dangerous version of this claim — some combo products carry very high D doses on exactly that reasoning.

  • Improves bone density or reduces fractures Limited evidence

    Combination trials are small and short, and none has fracture as an endpoint. The fracture data people cite for K2 come from 45 mg/day MK-4 in Japanese osteoporosis trials — roughly 100–450x the K2 dose in a typical D3+K2 capsule, in a different form, in trials with acknowledged methodological weaknesses.

  • The combination is convenient and low-risk Moderate evidence

    This is the honest positive. Both are fat-soluble and co-absorbed with a meal, K2 at supplemental doses has no known toxicity, and if you are taking vitamin D anyway and are not on a vitamin K antagonist, the added MK-7 costs little and does no harm. Buy it for convenience, not for the arterial calcium story.

Dosage & safety

Studied doseTypical products pair 1000–5000 IU (25–125 µg) of D3 with 45–200 µg of MK-7, or 1–5 mg of MK-4. The negative calcification trials used 720 µg/day MK-7 plus 1000 IU (25 µg) D3 for 24 months — meaning most combos deliver far less K2 than the dose that failed to work. Vitamin D's upper limit is 4000 IU/day for adults; take with a fat-containing meal.
SafetyThe K2 component antagonises warfarin and other vitamin K antagonists and can destabilise INR — do not start one without your prescriber's involvement. No interaction with DOACs. All vitamin D cautions apply: sustained intakes above 4000 IU/day risk hypercalcaemia, hypercalciuria and kidney stones, with particular danger in sarcoidosis and other granulomatous disease, lymphoma, primary hyperparathyroidism, and alongside thiazide diuretics or digoxin. Check the D dose on the label — 'D3+K2' products range from a sensible 1000 IU to 10,000 IU, and stacking one with a multivitamin and a fish oil that also contains D adds up fast. Not banned in sport.

Scientific references

Where to buy

California Gold Nutrition, Vitamin D3 + K2 as MK-7, 180 Veggie Capsules

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Heart & metabolic